First Tracks Biotherapeutics TRAX Cash Flow Statement (2024-2026)

NASDAQ TRAX
$46.56 -0.54 (-1.15%)
At close: Nov 16, 2026 · 4:00 PM EST
Reported Financials

First Tracks Biotherapeutics Quarterly Cash Flow Statement

Periods 8 quarters
Latest Sep 2026

First Tracks Biotherapeutics reported cash from operations of -$17.05M and free cash flow of -$17.05M for the quarter ended Sep 2026, up 44.4% year over year. This cash flow statement covers 8 quarters of results from Dec 2024 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income -162.60M-47.20M-42.45M-41.86M-34.59M-50.48M-33.37M-31.36M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.15M0.14M0.14M0.13M0.13M0.11M0.09M
Share-based CompensationStock Comp. 7.75M7.66M9.85M7.05M11.50M8.32M8.90M
Cash from Discontinued OperationsCash from Discont. Ops -45.01M-32.56M
Gains from Investment SecuritiesGains Investment 1.67M1.60M1.13M0.01M-0.15M
Other non-cash itemsOther Non-Cash 0.46M0.46M0.47M0.48M0.10M0.90M
Change in Working Capital 0.33M
Change in Accrued ExpensesChange Accrued Exp. -3.59M-3.46M3.87M-2.13M4.15M5.24M6.14M
Change in Other Operating AssetsOther Assets Change 0.44M-1.08M1.54M-0.49M-2.16M12.36M0.84M
Change in Other Operating LiabilitiesOther Liabilities Change -0.46M-0.48M-0.49M-0.49M-0.09M-0.89M
Other Working Capital ChangesOther WC Changes -2.03M0.00M-1.23M15.24M-1.73M
Cash from OperationsCash from Ops. -45.01M-38.64M-30.69M-28.59M-32.56M-31.92M-17.05M
Investing Activities
Capital ExpendituresCapex 0.04M0.04M0.01M-0.17M0.02M0.03M
Change in Property, Plant and EquipmentChange in PP&E -0.04M-0.04M-0.01M0.17M-0.02M-0.03M
Sale and Maturity of InvestmentsInvestments Sold 137.43M90.65M122.95M73.50M35.00M
Other Investing Activities (as filed)Other investing (as filed) 14.85M34.98M
Cash from Investing ActivitiesCash from Investing 14.85M36.40M103.28M73.50M34.98M-0.03M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued 5.72M-5.72M30.01M7.85M179.18M4.68M
Net Shares Issued and RepurchasedNet Shares Issued 5.72M-5.72M30.01M7.85M179.18M4.68M
Net Equity Issued and RepurchasedNet Equity Issued 5.72M-5.72M30.01M7.85M179.18M4.68M
Other financing activities (as filed) -0.49M
Cash from Financing ActivitiesCash from Financing 5.72M-52.11M-7.06M83.46M7.85M-48.51M4.66M
Additional items
Change in Cash -24.44M-54.34M65.54M128.36M10.27M-80.45M-12.39M
Ending Cash Balance 123.08M98.64M44.30M109.83M238.20M248.47M168.02M155.63M
Free Cash FlowFCF -45.04M-38.68M-30.70M-28.42M-32.58M-31.94M-17.05M
Net Cash FlowNCF -24.44M-54.34M65.54M128.36M10.27M-80.45M-12.39M

First Tracks Biotherapeutics Cash Flow Statement API

Pull First Tracks Biotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TRAX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY